Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 11391028)

1.

Are patients suffering from stable angina receiving optimal medical treatment?

Beaulieu MD, Blais R, Jacques A, Battista RN, Lebeau R, Brophy J.

QJM. 2001 Jun;94(6):301-8.

2.

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.

Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.

Am Heart J. 2003 Mar;145(3):438-44.

PMID:
12660666
3.

Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.

Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG; Canadian ACS Registries Investigators.

Am Heart J. 2007 Dec;154(6):1108-15. Epub 2007 Sep 14.

PMID:
18035083
4.

Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.

Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP; REACH Investigators.

Crit Pathw Cardiol. 2009 Sep;8(3):104-11. doi: 10.1097/HPC.0b013e3181b8395d.

PMID:
19726929
5.

Physicians' attitudes to the pharmacological treatment of patients with stable angina pectoris.

Beaulieu MD, Brophy J, Jacques A, Blais R, Battista RN, Lebeau R.

QJM. 2005 Jan;98(1):41-51.

6.
8.

Use of secondary preventive medications after the first attack of acute coronary syndrome.

Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):386-91.

PMID:
17568237
9.

Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.

Vermeer NS, Bajorek BV.

J Clin Pharm Ther. 2008 Dec;33(6):591-601. doi: 10.1111/j.1365-2710.2008.00950.x.

PMID:
19138236
10.

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.

Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology.

Eur Heart J. 2003 Mar;24(5):464-74.

11.

Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.

Mehta RH, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Brindis RG, Smith SC Jr, Harrington RA, Fintel D, Fraulo ES, Califf RM, Gibler WB, Ohman EM, Peterson ED.

Arch Intern Med. 2006 Oct 9;166(18):2027-34.

PMID:
17030838
12.

Health care services provided during physician office visits for hypertension: differences by specialty.

Fang J, Keenan NL, Ayala C.

J Clin Hypertens (Greenwich). 2010 Feb 1;12(2):89-95. doi: 10.1111/j.1751-7176.2009.00219.x.

PMID:
20167031
13.

Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention?

McCormick D, Gurwitz JH, Lessard D, Yarzebski J, Gore JM, Goldberg RJ.

Arch Intern Med. 1999 Mar 22;159(6):561-7.

PMID:
10090112
14.

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.

Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F; CPACS Investigators.

Am Heart J. 2009 Mar;157(3):509-516.e1. doi: 10.1016/j.ahj.2008.09.026. Epub 2008 Dec 17.

PMID:
19249422
15.
16.

Management of chronic stable angina pectoris.

Rodríguez-Ospina L, Montano-Soto L.

Bol Asoc Med P R. 2008 Oct-Dec;100(4):39-47. Review.

PMID:
19400528
18.

Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.

Mostaza JM, Lahoz C, Martín-Jadraque R, Sanmartín MA, Vicente I, Tranche S, Taboada M, Mantilla T, Monteiro B, Sanchez-Zamorano MA; PRESENAP study.

Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):34-8. doi: 10.1097/HJR.0b013e32831a47f3.

PMID:
19237995
19.

Drug treatment of stable angina pectoris and mass dissemination of therapeutic guidelines: a randomized controlled trial.

Beaulieu MD, Brophy J, Jacques A, Blais R, Battista R, Lebeau R.

QJM. 2004 Jan;97(1):21-31.

20.

Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).

Albert NM, Birtcher KK, Cannon CP, Goff DC Jr, Mulgund J, Liang L, Fonarow GC.

Am J Cardiol. 2008 May 1;101(9):1242-6. doi: 10.1016/j.amjcard.2007.12.020. Epub 2008 Mar 5.

PMID:
18435951
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk